U.S., Feb. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07398261) titled 'Efficacy of Mirabegron for Treatment of Non-monosymptomatic Nocturnal Enuresis in Children' on Aug. 29, 2023.
Brief Summary: This phase 3 clinical trial will compare use of individual treatment with mirabegron or desmopressin and their combination for treatment of non-monosymptomatic nocturnal enuresis in children
Study Start Date: Aug. 28, 2023
Study Type: INTERVENTIONAL
Condition:
Treatment of Non-monosymptomatic Nocturnal Enuresis
Intervention:
DRUG: Mirabegron 25 MG
Evaluate the efficacy of individual mirabegron or in combination for treatment of non-monosymptomatic nocturnal enuresis in children
Recruitment Status: ACTI...